For years, researchers puzzled over the "obesity paradox" in colorectal cancer (CRC) — the curious finding that overweight patients seemed to survive longer after diagnosis than those at normal weight. A new study published in JAMA Network Open offers a compelling explanation: it's not that extra weight is protective; it's that undetected, cancer-driven weight loss was skewing the data all along.

The study, drawing on data from over 5,500 German CRC patients enrolled between 2001 and 2016, found that when pre-diagnostic weight loss was factored in, the survival advantage associated with being overweight vanished. CRC often causes silent, unintentional weight loss months or even years before diagnosis — meaning a patient who appears "normal weight" at diagnosis may actually have been overweight before the cancer took hold.

By the Numbers:

• 5,521 patients analyzed (median age 69; 61% men)
• Overweight patients had an 11% lower risk of all-cause mortality vs. normal weight — but this disappeared after adjusting for pre-diagnostic weight loss
• Losing ≥10% body weight 5–14 years before diagnosis was linked to a 55% higher risk of death, 51% higher CRC-specific mortality, and 33% higher recurrence risk
• The effect held regardless of sex or cancer stage

Why it matters: Clinicians should resist interpreting the obesity paradox as a reason to encourage weight gain in normal-weight patients. A single BMI reading at diagnosis doesn't tell the full story — a patient's weight history carries critical prognostic information that could guide monitoring and early supportive care decisions.